Abstract

Pharmacognosy Magazine ,2019,15,61,317-321.DOI:10.4103/pm.pm_144_18Published:March 2019Type:Original Article Authors:Jun Yin, HyeSoo Wang, and MinWon Lee Author(s) affiliations:Jun Yin, HyeSoo Wang, MinWon Lee Laboratory of Pharmacognosy and Natural Product Derived Medicine, College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea Abstract:Context: Corylopsis coreana Uyeki (Korean winter hazel) belongs to the Hamamelidaceae family. It is cultivated as an ornamental plant in South Korea. In traditional folk medicine, C. coreana has been used to treat irritated skin and inflammatory diseases. Aims: To study the anti-inflammatory effects of C. coreana Uyeki leaf and bark extracts as well as their major active compounds, we evaluated in vitro levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and nitric oxide (NO) using RAW 264.7 macrophages. Materials and Methods: Production of TNF-α and IL-6 cytokines was measured by ELISA assay, and NO inhibitory activity was tested by Griess assay. Results: Extracts of leaves and barks, as well as isolated compounds from these extracts, showed remarkable anti-inflammatory activities by inhibiting NO, TNF-α, and IL-6 cytokine production. In particular, the leaf extract showed more potent inhibitory activities than that of barks. Conclusions: Ellagitannins and flavonoids were probably related to the anti-inflammatory activity of CL (leaves) extract, providing evidence of the anti-inflammatory property of CL. Keywords:Anti-inflammatory ability, Corylopsis coreana uyeki, cytokine production inhibition, interleukin-6, nitric oxide production inhibition, tumor necrosis factor-αView:PDF (1.08 MB)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call